Chad Tang, MD

MD Anderson Cancer Center
Houston, TX

Associate professor of radiation oncology at MD Anderson Cancer Center with a joint appointment in translational molecular pathology and investigational cancer therapeutics. Specializing in the treatment of genitourinary disease with an emphasis on kidney cancer, prostate cancer, and oligometastatic disease. Research focus on clinical trials with a strong translational component.

Disclosures:

  • Employment: MD Anderson Cancer Center:Hospital:Employee
  • Compensation: Diffusion Pharmaceutical: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: 01/01/2023 ;Siemen Helathineer: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria, Travel Expenses-End Date: 1/11/23 ;Lantheus: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria, Travel Expenses-End Date: 5/12/23 ;Merck: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Ongoing ;Telix: Advisory
  • Ownership: Stanford Office of Technology Licensing:Copyright;Wolter Kluwer:Copyright;Osler:Copyright
  • Leadership: none

Presentations

Sep 29

Discussant

05:50pm - 06:00pm PT
Sep 30

Case Discussions

03:40pm - 04:00pm PT